AAA raises €4.8m from Seventure et al.

The fresh funding will be used to expand the firm's product range in cancer diagnostics and treatment, and fuel its international expansion. AAA will also look to grow through strategic acquisitions.

Company
AAA was founded in 2002, when it span out from the European Organization for Nuclear Research (CERN). The firm develops and commercialises diagnostic and therapeutic applications and products. Its central research focuses on molecular imaging and personalised medicine for the treatment of diseases, including cancer.

AAA has 16 production and R&D facilities in France, Italy, Switzerland, Spain, Portugal, Israel and the US. The company has been profitable since 2006 and reported revenues of €44.6m and an EBITDA of €9.4m in 2012.

People
Sébastien Groyer is a partner at Seventure and worked on the deal.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France
• Healthcare
• Expansion
• France
• Seventure (SPEF)